| |
|
4. Statistical Considerations in Toxicity Studies
|
|
|
| |
|
5. Diets for Toxicity Studies
|
|
|
| |
|
a. Types of Diets
|
|
|
| |
|
i. Natural Ingredient Diets
|
|
|
| |
|
ii. Purified Diets
|
|
|
| |
|
b. Issues to Consider when Selecting Diets for Animals in Toxicity Studies
|
|
|
|
C.
|
|
Guidelines for Specific Toxicity Studies
|
|
|
| |
|
1. Short-Term Tests for Genetic Toxicity
|
|
|
| |
|
a. Bacterial Reverse Mutation Test
|
|
|
| |
|
b. In Vitro Mammalian Chromosome Aberration Test
|
|
|
| |
|
c. In Vitro Mouse Lymphoma TK+/– Gene Mutation Assay
|
|
|
| |
|
d. In vivo Mammalian Erythrocyte Micronucleus Test
|
|
|
| |
|
2. Acute Oral Toxicity Tests
|
|
|
| |
|
3. Short-Term Toxicity Tests with Rodents and Non-Rodents
|
|
|
| |
|
a. Short-Term Toxicity Studies with Rodents
|
|
|
| |
|
b. Short-Term Toxicity Studies with Non-Rodents
|
|
|
| |
|
4. Subchronic Toxicity Tests with Rodents and Non-Rodents
|
|
|
| |
|
a. Subchronic Toxicity Studies with Rodents
|
|
|
| |
|
b. Subchronic Toxicity Studies with Non-Rodents
|
|
|
| |
|
5. One-Year Long-Term Toxicity Tests with Non-Rodents
|
|
|
| |
|
6. Carcinogenicity Studies with Rodents
|
|
|
| |
|
7. Combined Chronic Toxicity/Carcinogenicity Studies with Rodents
|
|
|
| |
|
8. In Utero Exposure Phase for Addition to Carcinogenicity Studies with Rodents
|
|
|
| |
|
9. Reproduction and Developmental Toxicity Studies
|
|
|
| |
|
a. Guidelines for Reproduction Studies
|
|
|
| |
|
b. Guidelines for Developmental Toxicity Studies
|
|
|
| |
|
10. Neurotoxicity Studies
|
|
|
|
Chapter V.
|
|
Additional Recommended Studies
|
|
|
| |
|
A. Introduction
|
|
|
| |
|
B. Metabolism and Pharmacokinetic Studies
|
|
|
| |
|
1. Recommended Metabolism and Pharmacokinetic Studies
|
|
|
| |
|
2. Considerations in the Design of Pharmacokinetic Studies
|
|
|
| |
|
a. Test Substance
|
|
|
| |
|
b. Animals
|
|
|
| |
|
c. Route of Administration
|
|
|
| |
|
d. Dosage Regimen
|
|
|
| |
|
e. Sampling
|
|
|
| |
|
f. In Vitro Studies: Dose Response, Mechanism
|
|
|
| |
|
g. Analysis of Data
|
|
|
| |
|
h. Pregnancy/Lactation/Reproductive Studies
|
|
|
| |
|
3. Analysis and Use of Data from Pharmacokinetic Studies
|
|
|
| |
|
a. Data Reporting and Parameter Estimation
|
|
|
| |
|
b. Pharmacokinetic Models: Data Interpretation and Predicting Effects
|
|
|
| |
|
4. Use of Pharmacokinetic Results for Study Design and Risk Assessment
|
|
|
| |
|
a. Design of Toxicity Studies
|
|
|
| |
|
b. Setting Dose Levels
|
|
|
| |
|
c. Determining Mechanisms of Toxicity
|
|
|